Correlation of viral RNA, alanine aminotransferase, and histopathology in hepatitis C virus - associated hepatitis

被引:8
作者
Choi, Y
Putti, T
Win, K
Hu, Y
Remy, P
Bloom, A
机构
[1] Bronx Lebanon Hosp Ctr, Dept Pathol, Bronx, NY 10457 USA
[2] Bronx Lebanon Hosp Ctr, Dept Gastroenterol, Bronx, NY 10456 USA
来源
MOLECULAR DIAGNOSIS | 1999年 / 4卷 / 03期
关键词
viral load; PCR; chronic hepatitis; liver biopsy;
D O I
10.1016/S1084-8592(99)80029-0
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Background: Hepatitis C virus (HCV) infection is usually monitored by the level of alanine aminotransferase (ALT) and histopathological changes in liver biopsy specimens. However, accumulating data indicate these parameters are not always correlated with disease progression or the response of HCV infection to therapy. Materials and Methods: Using the Amplicor PCR Monitor Test Kit (Roche Diagnostic Systems, Branchburg, NJ), HCV RNA level was measured in 38 patients with positive anti-HCV antibodies and in 21 of those patients after interferon treatment. The grade and stage of histological changes on hematoxylin and eosin-stained sections of liver biopsy specimens were evaluated on a scale of 1 to 4. In each case, the HCV RNA level was compared with the histological grade or stage and level of ALT and statistically analyzed by Student's t-test. Results: ALT level did not correlate with pretreatment and posttreatment levels of HCV RNA or histopathological changes. However, there was a statistically significant correlation between HCV RNA and histological grade (P <.05). Conclusion: HCV RNA measurement is a better means of determining and monitoring HCV infection than either ALT level or histopathological characteristics and may provide insight into hepatic injury caused by HCV infection even without an invasive liver biopsy.
引用
收藏
页码:251 / 254
页数:4
相关论文
共 26 条
[1]   THE NATURAL-HISTORY OF COMMUNITY-ACQUIRED HEPATITIS-C IN THE UNITED-STATES [J].
ALTER, MJ ;
MARGOLIS, HS ;
KRAWCZYNSKI, K ;
JUDSON, FN ;
MARES, A ;
ALEXANDER, WJ ;
HU, PY ;
MILLER, JK ;
GERBER, MA ;
SAMPLINER, RE ;
MEEKS, EL ;
BEACH, MJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (27) :1899-1905
[2]   EPIDEMIOLOGY OF HEPATITIS-C IN THE WEST [J].
ALTER, MJ .
SEMINARS IN LIVER DISEASE, 1995, 15 (01) :5-14
[3]   CHRONIC HEPATITIS - AN UPDATE ON TERMINOLOGY AND REPORTING [J].
BATTS, KP ;
LUDWIG, J .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1995, 19 (12) :1409-1417
[4]   Limited utility of alanine aminotransferase screening of hepatitis C antibody-screened blood donors [J].
Cable, R ;
Badon, S ;
Pray, C ;
Popovsky, MA .
TRANSFUSION, 1997, 37 (02) :206-210
[5]  
Centers for Disease Control and Prevention, 1998, MMWR RECOMMEND REP, V47, P1
[6]  
CHOI Y, 1997, J KOREAN MED ASSOC, V4, P41
[7]   HEPATITIS-C - PROGRESS AND PROBLEMS [J].
CUTHBERT, JA .
CLINICAL MICROBIOLOGY REVIEWS, 1994, 7 (04) :505-&
[8]   Serum and liver HCV RNA levels in patients with chronic hepatitis C: correlation with clinical and histological features [J].
De Moliner, L ;
Pontisso, P ;
De Salvo, GL ;
Cavalletto, L ;
Chemello, L ;
Alberti, A .
GUT, 1998, 42 (06) :856-860
[9]   HEPATITIS-C - DIAGNOSTIC ASSAYS [J].
DEMEDINA, M ;
SCHIFF, ER .
SEMINARS IN LIVER DISEASE, 1995, 15 (01) :33-40
[10]   A LONG-TERM STUDY OF HEPATITIS-C VIRUS-REPLICATION IN NON-A, NON-B HEPATITIS [J].
FARCI, P ;
ALTER, HJ ;
WONG, D ;
MILLER, RH ;
SHIH, JW ;
JETT, B ;
PURCELL, RH .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (02) :98-104